MAZHAR H. GOLEWALE
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- Oswego, IL
- NPI
- 1104048446
- Received
- $120,871 in 397 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 133 | $43,531 |
| 2024 | General payment | 85 | $11,058 |
| 2023 | General payment | 34 | $816 |
| 2022 | General payment | 26 | $5,458 |
| 2021 | General payment | 44 | $15,267 |
| 2020 | General payment | 22 | $16,707 |
| 2019 | General payment | 53 | $28,032 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 52 | $96,431 |
| Consulting Fee | 4 | $12,675 |
| Food and Beverage | 327 | $9,948 |
| Travel and Lodging | 8 | $1,376 |
| Education | 6 | $440 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | Neos Therapeutics, LP | $17 | Food and Beverage | Cash or cash equivalent | EXXUA Drug, Adult Depression | 2025 | |
| 2025-12-09 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-05 | Vanda Pharmaceuticals Inc. | $29 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-12-04 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $117 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-22 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | Eisai Inc. | $115 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-14 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $119 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | Janssen Pharmaceuticals, Inc | $9 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-06 | Janssen Pharmaceuticals, Inc | $33 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-06 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-05 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $115 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-21 | Noven Therapeutics, LLC | $13 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-10-16 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-09 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-10-07 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $275 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $270 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $115 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-29 | Tris Pharma Inc | $17 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-09-24 | Eisai Inc. | $118 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-24 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-09-11 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-10 | Noven Therapeutics, LLC | $20 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-09-09 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-04 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-03 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-27 | ABBVIE INC. | $92 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-26 | Supernus Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-22 | Biogen, Inc. | $20 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, Neurology | 2025 | |
| 2025-08-21 | Noven Therapeutics, LLC | $20 | Food and Beverage | Cash or cash equivalent | Xelstrym Drug, ADHD | 2025 | |
| 2025-08-21 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-20 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-08-15 | Collegium Pharmaceutical, Inc. | $25 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-08-14 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-13 | Edwards Lifesciences Corporation | $13 | Food and Beverage | In-kind items and services | SAPIEN 3 Ultra RESILIA Device, Transcatheter Heart Valves | 2025 | |
| 2025-08-11 | Lundbeck LLC | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-06 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-01 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-31 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-24 | Janssen Pharmaceuticals, Inc | $29 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-24 | Tris Pharma Inc | $24 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-07-24 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-07-23 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-17 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-17 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-11 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-10 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-10 | Noven Therapeutics, LLC | $24 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-07-08 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-08 | Supernus Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-03 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,497 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-06-26 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-25 | ABBVIE INC. | $116 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-24 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-19 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-18 | Neos Therapeutics, LP | $15 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2025 | |
| 2025-06-12 | IDORSIA PHARMACEUTICALS US INC | $24 | Food and Beverage | In-kind items and services | Quviviq Drug, Insomnia | 2025 | |
| 2025-05-28 | Takeda Pharmaceuticals U.S.A., Inc. | $27 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-05-22 | Noven Therapeutics, LLC | $19 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-05-21 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-05-14 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-05-09 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-07 | Neurocrine BioSciences, Inc. | $1 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-06 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-24 | Neurocrine BioSciences, Inc. | $32 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-23 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-04-17 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-16 | Axsome Therapeutics, Inc. | $28 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-10 | Janssen Pharmaceuticals, Inc | $20 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-04-08 | Noven Therapeutics, LLC | $24 | Food and Beverage | In-kind items and services | Xelstrym Drug, ADHD | 2025 | |
| 2025-04-08 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-07 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-04-01 | Otsuka America Pharmaceutical, Inc. | $27 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-17 | Tris Pharma Inc | $21 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2025 | |
| 2025-03-13 | Teva Pharmaceuticals USA, Inc. | $30 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-03-11 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | E.R. Squibb & Sons, L.L.C. | $11 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-04 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | Axsome Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-02-25 | Collegium Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Jornay PM Drug, ADHD | 2025 | |
| 2025-02-19 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-18 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-04 | Biogen, Inc. | $22 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, Neurology | 2025 | |
| 2025-01-30 | Janssen Pharmaceuticals, Inc | $37 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-01-29 | Axsome Therapeutics, Inc. | $20 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-01-29 | Otsuka America Pharmaceutical, Inc. | $5 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-01-29 | Otsuka America Pharmaceutical, Inc. | $1 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-01-28 | Supernus Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-01-22 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-22 | Neurocrine BioSciences, Inc. | $0 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-13 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-09 | E.R. Squibb & Sons, L.L.C. | $31 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2024-12-17 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-16 | Tris Pharma Inc | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-13 | Janssen Pharmaceuticals, Inc | $11 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-12-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-12-03 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-03 | Janssen Pharmaceuticals, Inc | $30 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-12-03 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-11-27 | Alkermes, Inc. | $30 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-13 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-13 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-11-08 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-11-08 | Vanda Pharmaceuticals Inc. | $18 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-11-07 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-04 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-10-22 | Tris Pharma Inc | $23 | Food and Beverage | In-kind items and services | Dyanavel XR Drug, ADHD | 2024 | |
| 2024-10-17 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-10-16 | Tempus AI, Inc | $17 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-10-09 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-10-09 | Teva Pharmaceuticals USA, Inc. | $3 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-10-01 | Janssen Pharmaceuticals, Inc | $104 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-09-18 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-29 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-27 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-15 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-08-13 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-07 | Supernus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-02 | Supernus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-01 | ABBVIE INC. | $91 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-30 | Teva Pharmaceuticals USA, Inc. | $31 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-07-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-18 | Janssen Pharmaceuticals, Inc | $124 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-07-16 | Janssen Pharmaceuticals, Inc | $28 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-07-16 | Janssen Pharmaceuticals, Inc | $4 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-07-11 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-02 | Supernus Pharmaceuticals, Inc. | $31 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-02 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-07-02 | Supernus Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-06-12 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-07 | Janssen Pharmaceuticals, Inc | $6 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-06-05 | Janssen Pharmaceuticals, Inc | $104 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-06-05 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-06-04 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-04 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-30 | IRONSHORE PHARMACEUTICALS INC. | $19 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-05-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-28 | Teva Pharmaceuticals USA, Inc. | $6 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-23 | Janssen Pharmaceuticals, Inc | $29 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-22 | Otsuka America Pharmaceutical, Inc. | $113 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-05-22 | Neos Therapeutics, LP | $16 | Food and Beverage | Cash or cash equivalent | Adzenys XR-ODT Drug, ADHD | 2024 | |
| 2024-05-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-05-21 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-16 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-05-13 | ABBVIE INC. | $93 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-09 | Janssen Pharmaceuticals, Inc | $29 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-09 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-05-08 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-05-07 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-05-02 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-01 | Neurocrine BioSciences, Inc. | $31 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-30 | ABBVIE INC. | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-30 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-19 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-04-18 | Teva Pharmaceuticals USA, Inc. | $111 | Education | In-kind items and services | 2024 | ||
| 2024-04-16 | ABBVIE INC. | $99 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 |
The latest 200 records of 397.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Oswego, IL, county Kendall County, IL, state Illinois; placed by its city name.
| Measure | Place (city or town) Oswego, IL | County Kendall County, IL | State Illinois |
|---|---|---|---|
| Population B01003 | 36,375 | 137,675 | 12,694,798 |
| Population, 2020 census P1 | 34,585 | 131,869 | 12,812,508 |
| Median age B01002 | 38.7 | 36.3 | 39.0 |
| Under 18 B01001 | 26.3% | 27.0% | 21.8% |
| 65 and over B01001 | 11.0% | 11.2% | 17.0% |
| Households B11001 | 12,243 | 45,372 | 5,036,449 |
| Foreign born B05002 | 14.3% | 11.4% | 14.7% |
| Median household income B19013 | $123,792 | $111,601 | $83,390 |
| Median family income B19113 | $132,933 | $121,304 | $106,018 |
| Per capita income B19301 | $47,866 | $44,141 | $46,406 |
| Poverty rate B17001 | 2.6% | 5.4% | 11.8% |
| Unemployment rate B23025 | 2.6% | 4.3% | 5.8% |
| Civilian labor force B23025 | 19,835 | 76,164 | 6,652,134 |
| Mean commute (minutes) B08013 | 31.5 | 31.6 | 27.8 |
| Bachelor's degree or higher B15003 | 44.3% | 36.9% | 37.8% |
| Housing units B25001 | 12,440 | 46,589 | 5,457,452 |
| Owner-occupied B25003 | 87.9% | 84.0% | 67.1% |
| Renters B25003 | 12.1% | 16.0% | 32.9% |
| Median home value B25077 | $344,500 | $322,400 | $263,300 |
| Median gross rent B25064 | $1,860 | $1,781 | $1,274 |
| White, not Hispanic B03002 | 62.4% | 62.0% | 58.1% |
| Black B03002 | 10.1% | 7.6% | 13.3% |
| Hispanic or Latino B03002 | 17.9% | 22.4% | 18.8% |
| Asian B03002 | 4.4% | 3.5% | 5.9% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.1% |
Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Oswego, IL.
Comments